Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Calcium mandelate |
Is a |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ormetoprin (substance) |
Is a |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pipemidic acid |
Is a |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fosfomycin (substance) |
Is a |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methenamine (substance) |
Is a |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitrofurantoin (substance) |
Is a |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Urinary anti-infective |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trimethoprim (substance) |
Is a |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetohydroxamic acid (substance) |
Is a |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mandelic acid (substance) |
Is a |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Urinary antimicrobial drugs |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitrofuran derivative (substance) |
Is a |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hexamine |
Is a |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 80mg/400mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 160mg/800mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 120mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 240mg/5mL pediatric suspension (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 480mg/5mL intravenous infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 40mg/200mg/5mL pediatric s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely trimethoprim 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trimethoprim 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trimethoprim 50mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trimethoprim 20mg/mL injection solution 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sulfamethoxazole 100 milligram and trimethoprim 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 960mg/10mL intravenous infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oral sulfamethoxazole+trimethoprim |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing sulfamethoxazole and trimethoprim in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polymyxin B sulfate+trimethoprim eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polymyxin B sulfate+trimethoprim eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely trimethoprim 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing phenazopyridine hydrochloride and sulfamethoxazole and trimethoprim |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole [generic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole [proprietary] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polymyxin b sulfate + trimethoprim sulfate 10000unt/ns solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulphamethoxazole + trimethoprim 200mg/40mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfamethoxazole + trimethoprim 400mg/80mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfamethoxazole + trimethoprim 800mg/160mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 96mg/mL infusion solution 20mL ampule (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfamethoxazole 400mg/trimethoprim 80mg infusion solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfamethoxazole 80mg/trimethoprim 16mg infusion solution ampoule (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing sulfamethoxazole and trimethoprim (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polymyxin b sulfate + trimethoprim sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polymyxin B- and trimethoprim-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitroxoline |
Is a |
False |
Urinary anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|